Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations.

Published in: Journal of asthma and allergy (2024)

Our experience showed that tralokinumab is effective and safe in elderly patients and subjects affected by severe comorbidities.

Keyphrases